Assign DMB is an Austrian Contract Research Organisation (CRO) founded in 2005, providing clinical data management, biostatistics, safety, and project management services for drug, vaccine, and medical device studies. Since 2024, Assign DMB has been part of P95.
Honouring the Assign DMB Legacy
Since joining P95, Assign DMB has become part of a global organization dedicated to advancing high-quality clinical, epidemiological, and public health research.
This page honours the history, expertise, and people behind Assign DMB and explains how its legacy continues today within P95.
Assign DMB at a Glance
- Founded: 2005
- Founder: Dr. Anton Klingler
- Headquarters: Innsbruck, Austria
- Core expertise: Data Management, Biostatistics, Safety, Project Management
- Therapeutic focus: Drugs, vaccines, and medical devices
- Experience: 20+ years in clinical research
- Integrated into P95: 2024
A Foundation Built on Scientific Rigor
Assign DMB was founded in 2005 by Dr. Anton Klingler, whose background in mathematics and academic medicine shaped the organisation’s strong analytical foundation. After earning his degree in mathematics at the University of Innsbruck, Dr. Klingler served as Head of Theoretical Surgery at the Medical University of Innsbruck, where he deepened his expertise in clinical research.
Driven by a vision to combine mathematical precision with practical clinical research execution, he took the step into entrepreneurship and established Assign DMB as a specialised CRO focused on quality, efficiency, and tailored solutions for sponsors.
Growth, Expertise, and Impact
Over more than two decades, Assign DMB developed into one of Austria’s leading clinical research organisations, supporting sponsors across all phases of clinical development.
Key areas of expertise include:
- Data Management, including EDC system setup, database development, and database closure
- Biostatistics, covering statistical study design, analysis plans, programming, and reporting
- Safety Management, including SAE handling and regulatory reporting
- Project Management, ensuring efficient coordination across complex clinical studies
Assign DMB’s highly skilled, multinational team has supported clinical studies in drugs, vaccines, and medical devices, consistently delivering reliable results tailored to the individual needs of sponsors.
Expertise Shaped by People
A defining characteristic of Assign DMB has always been the continuity and depth of its expert team. Many team members built their careers within the organisation, contributing to its long-term stability and quality.
Leadership roles across key functions – including Data Management, Biostatistics, Safety, Project Management, and Code Development – ensured strong internal standards, process optimisation, and knowledge sharing across projects.
This people-driven approach enabled Assign DMB to maintain high quality while scaling its operations over time.
Assign DMB Today, Within P95
In 2024, Assign DMB joined P95, marking a new chapter in its development. This integration brought Assign DMB’s deep expertise in data-driven clinical research together with P95’s global scale and leadership in clinical, epidemiological, and public health research.
Today, the capabilities that defined Assign DMB – scientific rigor, operational efficiency, and highly specialised teams – continue within P95, strengthening our ability to support complex clinical development programs worldwide.
Continuing the Work at P95
The expertise, experience, and values that shaped Assign DMB remain central to the work we do at P95 today.
Looking for the data management, biostatistics, or safety expertise that Assign DMB was known for?
That work continues at P95.
Explore P95 Clinical Research Services
This page is part of the P95 Heritage Series, documenting the history of organisations that now form the P95 group. It has been prepared by P95 to honour the people, expertise, and legacy of Assign DMB.
0 Comments